Back to Results
First PageMeta Content
Thioethers / GlaxoSmithKline / Proton pump inhibitors / Pyridines / Sulfoxides / Ranitidine / Antacid / Dyspepsia / H2 antagonist / Medicine / Chemistry / Organic chemistry


Ranitidine HCl 150mg (Zantac Relief Tablets) GlaxoSmithKline Consumer Healthcare, February 2007 Ranitidine HCl 150mg (Zantac Relief Tablets) GlaxoSmithKline Consumer Healthcare, February 2007
Add to Reading List

Document Date: 2015-02-17 23:00:48


Open Document

File Size: 888,50 KB

Share Result on Facebook

Company

New Zealand Guidelines Group / GlaxoSmithKline New Zealand Ltd / Glaxosmithkline plc / /

Continent

Europe / North America / /

Country

Switzerland / Hungary / Netherlands / Norway / France / Canada / Australia / Slovakia / United Kingdom / Lithuania / Finland / Denmark / Germany / Italy / Slovenia / Sweden / New Zealand / Poland / Belgium / Austria / United States / Spain / Ireland / Czech Republic / /

Currency

USD / /

/

Event

Person Communication and Meetings / FDA Phase / /

Facility

TOWER Nov / Pharmacy Only Medicine / Pharmacy Only / /

/

IndustryTerm

antacid/alginate products / health care services / food / pharmaceuticals / healthcare professionals / treatment of heartburn and related symptoms / over-the-counter products / consumer healthcare brands / healthcare professional / treatment for acid-peptic disorders / non-prescription product / antacid/alginate combination products / healthcare seeking / important tool / proposed unscheduled product / prescription product / antacid solution / prevention of these symptoms / treatment of the chronic peptic diseases / excess gas / /

MedicalCondition

duodenal ulcer / alcohol abuse / hypochondriasis / peptic ulcer disease / tiredness / indigestion / neural tube defect / serious disease / foil blisters / specific disease / depression / gastro-oesophageal reflux / gastric cancer / recurrent upper abdominal pain / headache / serious underlying diseases / chronic peptic diseases / ectopic pregnancies / presentation Blister / constipation / cardiovascular disorders / disease / Gastro-oesophageal reflux disease / pain / blister / gastric acid-related diseases / /

MedicalTreatment

low-sodium diet / /

Organization

Canadian Therapeutic Products Directorate / Adverse Drug Reaction Advisory Committee / ADRAC Data Australia’s Adverse Drug Reaction Advisory Committee / Australian National Prescribing Service / MHRA / FDA / Teratology Information Service / Medicines Classicfication Committee / Federal Government / National Drugs and Poisons Scheduling Committee / Medicines and Healthcare Products Regulatory Agency / /

Person

Ian Adams / /

/

Position

United Kingdom General / physician / midwife / general practitioner / pharmacist / Director / Medical & Scientific Affairs Australasia / metabolism and renal excretion.41 This author / general sales outlets / general sales environment / /

Product

150mg / Ranitidine hydrochloride / sodium bicarbonate / cimetidine / Zantac 150mg / Digoxin / famotidine / Ciprofloxacin / Zantac / Relief Tablets / Ranitidine / norfloxacin / omeprazole / Zantac Relief 150mg / 75mg OTC / nizatidine / Sucralfate / H2 / /

SocialTag